Reports from Jeonbuk National University Provide New Insights into Non-Small Cell Lung Cancer [Zidesamtinib (Jideytro®): a new selective, brain-penetrant ROS1 inhibitor approved for the treatment of ROS1-positive non-small cell lung cancer]

Media coverage

• Title	Reports from Jeonbuk National University Provide New Insights into Non-Small Cell Lung Cancer [Zidesamtinib (Jideytro®): a new selective, brain-penetrant ROS1 inhibitor approved for the treatment of ROS1-positive non-small cell lung cancer]
  Media name/outlet	South Korea Daily Report
  Country/Territory	United States
  Date	26.08.27
  Persons	Sumi Lee